| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/14/2009 | WO2009039854A3 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 05/14/2009 | WO2009039361A3 Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid |
| 05/14/2009 | WO2009037357A4 Benzimidazole nf- kappab inhibitors |
| 05/14/2009 | WO2009036000A3 Methods of treating a microbial infection by modulating rnase-l expression and/or activity |
| 05/14/2009 | WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 05/14/2009 | WO2009033804A3 Use of gamma- endorphin as a therapeutic agent |
| 05/14/2009 | WO2009033803A3 Use of the pentapeptide drlds and gamma-endorphin as therapeutic agents |
| 05/14/2009 | WO2009033799A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009033754A8 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009029132A3 Antigen-binding proteins targeting s. aureus orf0657n |
| 05/14/2009 | US20090124681 Beta-lactone compounds |
| 05/14/2009 | US20090124658 Treatments for Viral Infections |
| 05/14/2009 | US20090124644 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
| 05/14/2009 | US20090124639 valacyclovir formulations |
| 05/14/2009 | US20090124636 Chemical compounds |
| 05/14/2009 | US20090124635 Chemical compounds |
| 05/14/2009 | US20090124634 Novel dipodazine compounds and applications |
| 05/14/2009 | US20090124632 Methods and kits related to the topical administration of quinolone antibiotics° |
| 05/14/2009 | US20090124611 Pyrazolopyridine-1,4-Diamines and Analogs Thereof |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124583 7-N-substituted phenyl tetracycline compounds |
| 05/14/2009 | US20090124567 Influenza Therapeutic |
| 05/14/2009 | US20090124563 Oral extended-release composition |
| 05/14/2009 | US20090124554 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/14/2009 | US20090124547 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain |
| 05/14/2009 | US20090124545 Novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090124539 Methods of treating infection |
| 05/14/2009 | US20090124536 Calcium phosphate/sulfate-based bone implant composition |
| 05/14/2009 | US20090123574 Compositions for the regression of spongiform pustules |
| 05/14/2009 | US20090123569 Coverage indicating technology for skin sealants using tannates |
| 05/14/2009 | US20090123530 Liposome Drug Delivery |
| 05/14/2009 | US20090123529 Nucleic acid immunological composition for human metapneumovirus |
| 05/14/2009 | US20090123522 Medicament Delivery Device and a Method of Medicament Delivery |
| 05/14/2009 | US20090123516 Drug delivery from implants using self-assembled monolayers-therapeutic sams |
| 05/14/2009 | US20090123512 Quorum Sensing Modulators |
| 05/14/2009 | US20090123500 Active immunization using a siderophore receptor protein |
| 05/14/2009 | US20090123499 Vaccine |
| 05/14/2009 | US20090123493 Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector |
| 05/14/2009 | US20090123492 Generation of new bcg vaccine strains protecting against the establishment of latent mycobacterium tuberculosis infection and reactivation from the latent or persistent state |
| 05/14/2009 | US20090123439 Diagnostic and prognosis methods for cancer stem cells |
| 05/14/2009 | US20090123429 Arthrospira-based compositions and uses thereof |
| 05/14/2009 | US20090123425 Macrocyclic, pyridazinone-containing hepatitis c serine protease inhibitors |
| 05/14/2009 | US20090123423 Hydroxyamic analogs as hepatitis c virus serine protease inhibitor |
| 05/14/2009 | US20090123420 Regulation of T Cell-Mediated Immunity by D Isomers of Inhibitors of Indoleamine-2,3-Dioxygenase |
| 05/14/2009 | US20090123417 Recombinant super-compound interferon and uses thereof |
| 05/14/2009 | DE19638870B4 Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel Tubulysins, process for their production and to compositions comprising |
| 05/14/2009 | DE102007052223A1 Hydrolysate aus Pflanzenextrakten sowie diese enthaltendes antibakterielles Mittel Hydrolysates of plant extracts containing them and antibacterial agent |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2705007A1 Compositions and methods for treatment of microbial disorders |
| 05/14/2009 | CA2704977A1 Prevention and treatment of secondary infections following viral infection |
| 05/14/2009 | CA2704649A1 Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities |
| 05/14/2009 | CA2704556A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | CA2704549A1 Use of oligonucleotides with modified bases as antiviral agents |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058006A1 Anti-CCR5 antibody |
| 05/13/2009 | EP2057989A1 Freeze-dried preparation of 1-methylcarbapenem |
| 05/13/2009 | EP2057988A1 Nail patch |
| 05/13/2009 | EP2057985A1 Coated tablet |
| 05/13/2009 | EP2057268A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 05/13/2009 | EP2057185A1 Polymyxin derivatives and uses thereof |
| 05/13/2009 | EP2057173A1 Amides as sphingomyeline inhibitors |
| 05/13/2009 | EP2057165A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 05/13/2009 | EP2057127A1 Hydantoin derivatives useful as antibacterial agents |
| 05/13/2009 | EP2057125A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/13/2009 | EP2056865A2 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 05/13/2009 | EP2056864A2 Candidates against infection |
| 05/13/2009 | EP2056848A2 Use of extracts for the treatment of viral disorders |
| 05/13/2009 | EP2056845A2 Structure and use of 5' phosphate oligonucleotides |
| 05/13/2009 | EP2056843A2 Use of c7 sugars in prevention and treatment of mycoses |
| 05/13/2009 | EP2056820A2 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP1843749B1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 05/13/2009 | EP1753712B1 Amino-propanol derivatives |
| 05/13/2009 | EP1711485B1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 05/13/2009 | EP1469866B1 Cycloglycans suitable to inhibit mammalian infection |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1324736B1 Rapid antibiotic susceptibility test |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1294891B1 Transport peptides derived from erns protein |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN101432428A Recombinant human interferon-like proteins |
| 05/13/2009 | CN101432278A Diketo-piperazine and piperidine derivatives as antiviral agents |
| 05/13/2009 | CN101432021A Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 05/13/2009 | CN101429236A Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof |
| 05/13/2009 | CN101429232A Hcv protease inhibitors |
| 05/13/2009 | CN101429202A Cephalosporium acremonium corda rhzomorph, production method and uses thereof |
| 05/13/2009 | CN101429187A Ketone compound, preparation method and application thereof |
| 05/13/2009 | CN101429185A Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429184A Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429181A P-hydroxybenzene acrylic acid derivative and uses thereof |
| 05/13/2009 | CN101429155A Azacyclo-amino substituted tetracycline derivant |
| 05/13/2009 | CN101429142A Nitrogen-containing polyhydroxy fragrant compounds, preparation and uses thereof |
| 05/13/2009 | CN101429141A Glycinamide alkyl oxanamide tetracycline derivants |
| 05/13/2009 | CN101429107A Lignanoid compounds, producing method, identification method and uses thereof |
| 05/13/2009 | CN101428144A Polysaccharide combined vaccine for epidemic encephalitis and preparation method thereof |